Ovarian tumors of low malignant potential

ONCOLOGY

Volumn 17, Issue 11, 2003, Pages 1563-1567

  Trimble, Cornelia Liu ^a   Trimble, Edward L ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CARCINOMA; FEMALE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; OVARY TUMOR; PATHOLOGY; PROGNOSIS; REVIEW; RISK FACTOR;

CARCINOMA; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; OVARIAN NEOPLASMS; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 2142786708     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Lawrence WD: The borderland between benign and malignant surface epithelial ovarian tumors. Current controversy over the nature and nomenclature of "borderline" ovarian tumors. Cancer 76(10 suppl):2138-2142,1995.
2. Jazaeri AA, Yee CJ, Sotiriou C, et al: Gene expression profiles of BRCA1-linked, BRCA2- linked, and sporadic ovarian cancers. J Natl Cancer Inst 94:990-1000, 2002.
3. Schwartz DR, Kardia SL, Shedden KA, et al: Gene expression in ovarian cancer reflects both morphology and biologic behavior, distinguishing clear cell from other poor-prognosis ovarian cancers. Cancer Res 62:4722-4729, 2002.
4. Prat J: Ovarian tumors of borderline malignant (tumors of low malignant potential): A critical appraisal. Adv Anal Pathol 6:247-274, 1999.
5. McCluskey LL, Dubeau LL: Biology of ovarian cancer. Curr Opin Oncol 9:465-470, 1997.
6. Buttin BM, Herzog TJ, Powell MJD, et al: Epithelial ovarian tumors of low malignant potential: The role of microinvasion. Obstet Gynecol 99:11-17, 2002.
7. Gershenson DM, Silva EG, Levy L, et al: Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 82:1096-1103, 1998.
8. Morice P, Camatte S, Rey A, et al: Prognostic factors for patients with advanced stage serous borderline tumors of the ovary. Ann Oncol 14:592-598, 2003.
9. Gilks CB, Alkkushi A, Yue JJ, et al: Advanced-stage serous borderline tumors of the ovary: A clinicopathological study of 49 cases. Int J Gynecol Pathol 22:29-36, 2003.
10. Bell KA, Smith Sehdev AE, Kurman RJ: Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol 25:419-432,2001.
11. Ronnett BM, Shmookler BM, Diener- West M, et al: Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 16:1-9, 1997.
12. Lee KR, Scully RE: Mucinous tumors of the ovary: A clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei.' Am J Surg Pathol 24:1447-1464, 2000.
13. Burks RT, Sherman ME, Kurman RJ: Micropapillary serous carcinoma of the ovary: A distinctive low-grade carcinoma related to iserous borderline tumors. Am J Surg Pathol 20:1319-1330, 1996.
14. Eichhorn JH, Bell DA, Young RH, et al: Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases of comparison with 44 cases without these patttems. Am J Surg Pathol 23:397-409, 1999.
15. Dietel M, Hauptmann S: Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology. Virchows Arch 436:403-412, 2000.
16. Trimble EL, Trimble CL: Epithelial ovarian tumors of low malignant potential, in Markman M, Hoskins WJ (eds): Cancer of the Ovary- New York, Raven Press, 1993.
17. Shi Y, Ye F, Lu W, et al: Histologic classification in 10,288 cases of ovarian malignant tumors in China. Chinese J Obstet Gynecol 37:97-100, 2002.
18. Harlow BL, Weiss NS, Lofton S: Epidemiology of borderline ovarian tumors. J Nail Cancer Inst 78:71-74, 1987.
19. Trimble CL, Kosary C, Trimble EL: Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol 86:34-37, 2002.
20. Bjorge T, Engleand A, Hansen S, et al: Prognosis of patients with ovarian cancer and borderline tumors diagnosed in Norway between 1954 and 1993. Int J Cancer 75:663- 670, 1998.
21. Seidman JH, Kurman RJ: Ovarian serous borderline tumors: A critical review of the literature with emphasis on prognostic indicators. Hum Pathol 31:539-557, 2000.
22. Zanetta G, Rota S, Chiari S, et al: Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: A prospective study. J Clin Oncol 19:2658-2664, 2001.
23. Harris R, Whittemore AS, Itnyre J: Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potenitial in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136:1204-1211, 1992.
24. Gottlieb WH, Friedman E, Bar-Sade RB, et al: Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors. J Natl Cancer Inst 90:995-1000, 1998.
25. Parazzini F, Negri E, La Vecchia C, et al: Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol 68:226-228, 1998.
26. Ness RB, Cramer DW, Goodman MT, et al: Infertility, fertility drugs, and ovarian cancer: A pooled analysis of 8 case-control studies. Am J Epidemiol 155:217-224, 2002.
27. Eltabbakh GH, Natarajan N, Piver MS, et al: Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. Gynecol Oncol 74:103-107, 1999.
28. Riman T, Dickman PW, Nillson S, et al: Risk factors for epithelial borderline tumors: Results of a Swedish case control study. Gynecol Oncol 83:575-585, 2001.
29. Sengupta PS, Shanks JH, Buckley CH, et al: Requirement for expert histopathologic assessment of ovarian cancer and borderline tumors. Br J Cancer 82:760-762, 2000.
30. Yeo EL, Yu, KM, Poddar. MC, et al.:'The accuracy of intraoperative frozen section in the diagnosis of ovarian tumors. J Obstet Gynaecol Pes 24:189-915, 1998.
31. Houck K, Nikrui N, Duska L, et al: Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol 95:189-915, 2000.
32. Kayicioglu Fl, Pata O, Cengiz S, et al: Accuracy of frozen section diagnosis in borderline ovarian malignancy. Gynecol Obstet Invest 49:187-189, 2000.
33. Pinto PB, Andrade LA, Derchain SF: Accuracy of intraoperative frozen section diagnosis of ovarian tumors. Gynecol Oncol 81:230-232, 2001.
34. Darai E, Teboul J, Fauconnier A, et al: Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand 77:451-457, 1998.
35. Piu PA, Gershenson DM, Bevers MW, et al: The current status of surgical staging of ovarian serous borderline tumors. Cancer 85:905-911, 1999.
36. Malik E, Bohm W, Stoz F, et al: Laparoscopic management of ovarian tumors. Surg Endosc 12:1326-1333, 1998.
37. Urlich U, Paulus W, Schneider A, et al: Laparoscopic surgery for complex ovarian masses. J Am Assoc Gynecol Laparosc 7:373-380, 2000.
38. Barnhill DR, Kurman RJ, Brady MF, et al: Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: A Gynecologic Oncology Group study. J Clin Oncol 13:2752-2756, 1995.
39. Trope C, Kaern J, Vergote I, et al: Are borderline tumors of the ovary overtreated both surgically and systematically: A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol 51:236-243, 1993.
40. Ovarian cancer: Screening, treatment, and follow-up. NIH Consensus Statement, April 5-7, 1994. 12(3):l-30.
41. Kaern J, Trope CG, Kristensen GB, et al: DNA ploidy: The most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 3:349-358, 1993.
42. Gershenson DM, Deavers M, Diaz S, et al: Prognostic significance of p53 epxrssion in advanced-stage ovarian serous borderline tumors. Clin Cancer Res 5:4053-4058, 1999.
43. Frigerio L, Agnello A, Sassi E, et al: Adjuvant role of MIB1 index in differentiating serous ovarian tumors-preliminary report. Anticancer Research 17(2B):1287-1292, 1997.
44. Baak KPA, Van der Ley G: Borderline or malignant ovarian tumor: a case report of decsion making with morphometry. J Clin Pathol 37:1110-1113, 1984.
45. Kurman RJ, Trimble CL: The behavior of serous tumors of low malignant potential: are they ever malignant? Int J Gynecol Pathol 12:120-127, 1993.
46. Crispens MA, Bodurka D, Deavers M, et al: Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstet Gynecol 99:3-10, 2002.
47. Zanetta G, Rota S, Lissoni A: Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. Gynecol Oncol 81:63-66, 2001.
48. Camatte S, Morice P, Pautier P: Fertility results of conservative treatment of advanced stage serous borderline tumor of the ovary. Br J Obslet Gynecol 109:376-380, 2002.
49. Morris RT, Gershenson DM, Silva EG, et al: Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 95:541-547, 2000.
50. Papadimitriou DS, Martin-Hirsch P, Kitchener HC, et al: Recurrent borderline ovarian tumors after conservative management in women wishing to retain their fertility. Eur J Gynaecol Oncol 20:94-97, 1999.
51. Duska LR, Change YC, Flynn CE, et al: Epithelial ovarian carcinoma in the reproductive age group. Cancer 85:2623-2629. 1999.
52. Gotleib WH, Flikker S, Davidson B, et al: Borderline tumors of the ovary: Fertility treatment, conservative management, and pregnancy outcome. Cancer 82:141-146, 1998.
53. Gallot D, Pouly JL, Janny L, et al: Successful transfer of frozen-thawed emryos obtained immediated before radical surgery for stage IIIA serous borderline ovarian tumor: Case report. Hum Reprod 15:2347-2350, 2000.